Skip to main content
. 2014 Mar 21;165(6):814–823. doi: 10.1111/bjh.12835

Table IV.

Maximum percent change from baseline in bALP by use of bisphosphonates

Sotatercept dose group
Parameter Placebo (n = 6) 0·1 mg/kg (n = 8) 0·3 mg/kg (n = 8) 0·5 mg/kg (n = 8)
No bisphosphonates
n 3 4 6 4
 bALP, max. mean change from baseline (%) 39·2 22·7 36·9 104·4
Bisphosphonates
n 3 4 2 4
 bALP, max. mean change from baseline (%) 25·6 348·5 11·3 6·6

bALP, bone-specific alkaline phosphatase.